TLR9 resides in the endoplasmic reticulum and its activation results in increased production of inflammatory mediators[5,6], Except plasmacytoid DC and B cells, TLR9 can also expressed in breast[7], gastric[8], lung[9] and prostate[10] cancer cells. The gene discussed is TLR9; the disease is cancer.